Psychiatric comorbidity measures as predictors of retention in drug abuse treatment programs
about
Impact of co-occurring psychiatric disorders on retention in a methadone maintenance program: an 18-month follow-up studyInteraction of motivation and psychiatric symptoms on substance abuse outcomes in sober living houses.Personality Traits and Their Relationship to Demographic Features in Addicts Referring to a Drug Rehabilitation Center in the City of Isfahan, Iran.Patterns of drug use and expectations in methadone patients.A preliminary 6-month prospective study examining self-reported religious preference, religiosity/spirituality, and retention at a Jewish residential treatment center for substance-related disorders.Co-occurring disorders in substance abuse treatment: issues and prospectsThe influence of legal coercion on dropout from substance abuse treatment: results from a national survey.Treatment compliance in patients with comorbid psychiatric and substance use disordersAdapting Motivational Interventions for Comorbid Schizophrenia and Alcohol Use Disorders.Antisocial behavioral syndromes and DSM-IV drug use disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions.Course of Psychiatric Symptoms and Abstinence among Methamphetamine-Dependent Persons in Sober Living Recovery Homes.The effect of matching comprehensive services to patients' needs on drug use improvement in addiction treatment.Social Support Influences on Substance Abuse Outcomes Among Sober Living House Residents with Low and Moderate Psychiatric Severity.
P2860
Q33565738-C3C04A77-170A-4DFF-BEBD-38A1E1834738Q34614735-B5463CE3-9907-4EA5-AB1E-6F0C209CF3E3Q35639398-F218307C-080D-49C1-AC5B-21D88C5E6A9BQ35944946-9F00C31B-4179-4743-A5E2-0D5FB57BD131Q36105144-132CACCE-351A-4393-A0F4-BB6A202FA5FEQ36384556-9FB6E519-4BE1-4475-A76E-E12902F0A95AQ36492527-FD79375F-0972-43F5-BB97-D2EC8AAE0592Q37008441-9497E4A1-695C-4D63-855B-A35E0771F7C3Q37010033-AD4E759B-774F-43D0-9BBF-445C1536BAD4Q37077891-07E598B2-19BF-4361-B02C-D20A6B227CA4Q37095626-09021F9A-9E29-4909-8481-075C6AA183B7Q37386707-2A2014FA-BF8C-4762-B6EA-0BF0FADABF70Q47657689-C2BB136D-F1E0-4677-B81E-7892780F7229
P2860
Psychiatric comorbidity measures as predictors of retention in drug abuse treatment programs
description
1999 nî lūn-bûn
@nan
1999 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Psychiatric comorbidity measur ...... drug abuse treatment programs
@ast
Psychiatric comorbidity measur ...... drug abuse treatment programs
@en
type
label
Psychiatric comorbidity measur ...... drug abuse treatment programs
@ast
Psychiatric comorbidity measur ...... drug abuse treatment programs
@en
prefLabel
Psychiatric comorbidity measur ...... drug abuse treatment programs
@ast
Psychiatric comorbidity measur ...... drug abuse treatment programs
@en
P2093
P2860
P1476
Psychiatric comorbidity measur ...... drug abuse treatment programs
@en
P2093
D D Simpson
K M Broome
P2860
P304
P577
1999-08-01T00:00:00Z